default author photo

Keith R. Jerome

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division

Seattle, WA 98109-1024

United States

SCHOLARLY PAPERS

3

DOWNLOADS

299

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial

Number of pages: 43 Posted: 09 Dec 2020
University of Washington, University of Washington - Vaccine and Infectious Disease Division, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Division of Allergy and Infectious Diseases, School of Public Health and Tropical Medicine, Tulane University, School of Medicine, Tulane University, John H. Stroger, Jr., Hospital of Cook County, John H. Stroger, Jr., Hospital of Cook County, Boston University School of Medicine, Walter Reed Army Institute of Research - Clinical Trials Center, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Vaccine and Infectious Disease Division, University of Washington, New York University (NYU) - Grossman School of Medicine, Division of Cardiology, University of Washington, Division of Cardiology, University of Washington, Mayo Clinic, Mayo Clinic, Department of Global Health, University of Washington, Department of Laboratory Medicine and Pathology, University of Washington, University of Washington - Department of Laboratory Medicine and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Clinical Research Division, University of Washington - Department of Global Health, University of Washington - Division of Allergy and Infectious Diseases, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Department of Global Health and Independent
Downloads 131 (554,631)
Citation 2

Abstract:

Loading...

coronavirus, COVID-19, SARS-CoV-2, hydroxychloroquine, azithromycin, early treatment, remote enrollment, randomized controlled trial

Towards Discovering SARS-CoV-2 Variants of High Consequence Based on Both Surveillance and Electronically Captured Health Data: First Year Experience in Washington State (January 2020-2021)

Number of pages: 35 Posted: 30 Jul 2021
Fred Hutchinson Cancer Research Center - Division of Public Health Sciences, University of Washington - Department of Laboratory Medicine and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Clinical Research Division, Vanderbilt University - Department of Chemistry, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Laboratory Medicine and Microbiology, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division and Fred Hutchinson Cancer Research Center - Clinical Research Division
Downloads 63 (947,975)
Citation 1

Abstract:

Loading...

dynamics, emergence, haplotype, mutation, severe COVID, single nucleotide variant (SNV), transitory variant, variant, SARS-CoV-2, sequencing

3.

Rapidly Identifying New Coronavirus Mutations of Potential Concern in the Omicron Variant Using an Unsupervised Learning Strategy

Number of pages: 28 Posted: 11 Jan 2022
Fred Hutchinson Cancer Research Center, Vanderbilt University - Department of Chemistry, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Clinical Research Division, Fred Hutchinson Cancer Research Center - Clinical Research Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 105 (664,543)

Abstract:

Loading...

Omicron, haplotype, mutation, polymutant, SARS-CoV-2, single nucleotide variant, substitution, unsupervised machine learning